eli lilly retatrutide trial BEYOND OZEMPIC: WEIGHT LOSS TRIALS Clinical results for Eli Lilly's retatrutide show adults losing up to 30 percent of their body weight, far outperforming current options. https://blkcosmo.com/ retatrutide-weight-loss-trials Lilly's triple agonist delivers up

In Massachusetts, we can and should do better than that

Book your private blood test today and get clear, personalised results with clinician interpretation

Clinical trials show combination therapy produces an average weight loss of 8 to 12 pounds beyond what either drug achieves individually

This dual-modality strategy leverages the metabolic benefits of GLP-1 receptor agonists with the targeted fat-reduction effects of body contouring devices, delivering transformative results without surgery

#SIBpeople #SIBreading SIB LEX To view or add a comment, sign in Canada Approves First Generic Ozempic

Navigating cost and access barriers for medications in the treatment of obesity: A guide for patients and primary care clinicians, Clinical Diabetes